Skip to main content
Sign In

Contact Information

JFK Partners

Anschutz Medical Campus
Education 2 South, 5th Fl
13121 E. 17th Ave., C234
Aurora, CO 80045
Main: 303-724-5266
Clinical: 720-777-6630
JFK Fax: 303-724-7664

Find Faculty and Staff

Map and Directions

1in59 ADDM sites with ASD 2018.jpg


Autism & Developmental Disabilities Monitoring (ADDM)

The Colorado Autism and Developmental Disabilities Monitoring Program is a joint effort between the Colorado Department of Public Health and Environment (CDPHE) and JFK Partners. CDPHE is the lead agency for this application. The catchment area will include the seven-county, Denver Metropolitan area (Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas and Jefferson counties) with an eight-year-old population of 34,689 based on the 2003 post-censal estimate.

In an effort to better understand the prevalence and population characteristics of Autism Spectrum Disorders (ASD), CO ADDM plans to continue to conduct multiple-source surveillance of eight-year-old children.  We are also applying for supplemental funding to begin surveillance of four-year-old children.  The activities and methods for this project will follow the MADDSP model.  CO ADDM plans to request records from clinical, school, and other sources that provide evaluation services for children with ASD, conduct residency checks, review and abstract records if triggers are present, review composite records for DSM-IV criteria and determine final case status.

Major Goals:

  • Enhance our current population-based epidemiological surveillance system of ASD among eight-year-old children;
  • Begin surveillance among four-year-old children; and 3) collaborate with other ADDM Network partners on a common protocol by working collaboratively through committees and workgroups.

Under this funding, this project will complete surveillance results for two birth cohorts during the project period.  This project’s use of a team of clinicians and researchers experienced in epidemiology and autism maximize the likelihood that its findings will be useful to the public health, clinical and scientific communities.

For more information about ADDM, click here to see the Community Report on Autism 2018.